Quantcast NEUROCRINE BIOSC RG Stock Quote | Stock Price for NBIX | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
NEUROCRINE BIOSC RG (NQ: NBIX)
101.79 USD  -1.66 (-1.60%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 547,031
Open 103.80
Bid (Size) 100.88 (200)
Ask (Size) 108.00 (300)
Prev. Close 103.45
Today's Range 101.49 - 103.80
52wk Range 44.75 - 106.26
Shares Outstanding 89,897,863
Dividend Yield N/A
Performance
YTD
+28.36%
+28.36%
1 Month
+8.20%
+8.20%
3 Month
+24.90%
+24.90%
6 Month
+41.71%
+41.71%
1 Year
+116.02%
+116.02%
Top News
More News
Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego
Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a San Diego based biotechnology company focused on neurological and endocrine related disorders, is proud to announce that Kevin Gorman, Ph.D., Chief... Read More
from PR Newswire
Factors of Influence in 2018, Key Indicators and Opportunity within Fred's, Nexstar Broadcasting Group, CNO Financial Group, Neurocrine Biosciences, Kosmos Energy, and Loews — New Research Emphasizes
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fred's, Inc. (NASDAQ:FRED),... Read More
from GlobeNewswire News Releases
More News
Read More
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
from PR Newswire
Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia in Patients Treated with Antipsychotics
from PR Newswire
Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting
from PR Newswire
Notable Wednesday Option Activity: NBIX, APA, CVI
category Stocks
from Market News Video
Neurocrine Biosc Shares Up 26.7% Since SmarTrend's Buy Recommendation (NBIX)
from Comtex SmarTrend® News Briefs
Interesting NBIX Put And Call Options For February 2019
category Stocks
from Market News Video
Watch for Continued Gains in Shares of Neurocrine Biosc (NBIX)
from Comtex SmarTrend® News Briefs
Notable Tuesday Option Activity: CUB, AMTD, NBIX
category Stocks
from Market News Video
Neurocrine Biosc Has Returned 23.7% Since SmarTrend Recommendation (NBIX)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.